# UC Davis Multi-Disciplinary Cancer Research Training Program to Advance Precision Cancer Prevention and Care in Latin America.

> **NIH NIH D43** · UNIVERSITY OF CALIFORNIA AT DAVIS · 2024 · $34,236

## Abstract

PROJECT SUMMARY
Improvements in health care access and infection control have led to life expectancy increases in Low- and
Middle-Income Countries (LMICs) in Latin America. As the population ages, the Latin American cancer burden
has dramatically increased. By 2030, Latin America is expected to have annual averages of 1.6M new cancer
cases and 1M cancer deaths. A Latin America Lancet Oncology Commission report highlighted the small
amount of preclinical and clinical oncology research originating in the region as a limitation to control cancer
burden. Colombia and Peru, the Latin American LMICs with the first and second largest populations, have
state-funded national cancer institutes (NCIs) that are cancer treatment reference centers, and which lead
national efforts in cancer control and care. However, cancer risk assessment and patient treatment at these
institutions is primarily based on tools developed in North American and European patients. Despite having
exceptional researchers and physicians, most cancer centers in Latin America lack training programs that
would allow them to develop or adapt precision prevention or treatment tools that are appropriate to the
ancestry or mutation profiles of individuals from the region. The current funding opportunity is the ideal
program to formalize and enhance ongoing collaborations between US-based healthcare researchers and
providers in Colombia and Peru. It will provide a solid foundation for precision oncology research knowledge
transfer and to build local human capital necessary to develop precision cancer medicine in Latin America.
Building on our extensive expertise on Latin American population demography, cancer epidemiology and
genetics, NIH funded cancer studies in Latino populations, and a strong track record of research collaboration
and training with Colombian and Peruvian researchers, the overall goals of the UC Davis Multidisciplinary
Cancer Research Training Program to Advance Precision Cancer Prevention and Care in Latin America are to:
1) Enhance local capacity for precision cancer medicine research in Colombia and Peru by implementing a
curriculum that complements and addresses gaps in local training programs and provides hands on experience
and support for research project development relevant to the region, 2) Provide hands on training on research
resource development including ethics training, biobanking best practices, and cloud-based bioinformatics; and
3) allocate pilot funding for mentored research for basic science and clinically-oriented term trainees. We
propose to establish a curriculum to train graduate students and postdoctoral/clinical fellows in precision
oncology research. We will prepare trainees to implement and share their new skills in their home countries
and to collaborate with U.S-based investigators. We will leverage ongoing collaborations among the program
Principal Investigators, universities, and NCIs of Colombia and Peru to identify relevant areas of resear...

## Key facts

- **NIH application ID:** 10909271
- **Project number:** 5D43CA260869-03
- **Recipient organization:** UNIVERSITY OF CALIFORNIA AT DAVIS
- **Principal Investigator:** Luis Guillermo Carvajal Carmona
- **Activity code:** D43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $34,236
- **Award type:** 5
- **Project period:** 2022-09-01 → 2028-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10909271

## Citation

> US National Institutes of Health, RePORTER application 10909271, UC Davis Multi-Disciplinary Cancer Research Training Program to Advance Precision Cancer Prevention and Care in Latin America. (5D43CA260869-03). Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/grant/nih/10909271. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
